Ardelyx to Present at the Jefferies 2023 Healthcare Conference
WALTHAM, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, president and chief executive officer of Ardelyx, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 7, 2023, at 8:30 a.m. ET in New York City.
To access the live webcast of Ardelyx's fireside chat please visit the Events & Presentations page within the Investor section of the Ardelyx website at ir.ardelyx.com. A replay of the webcast will be available on the Ardelyx website for 30 days following the event.
About Ardelyx, Inc.
Investor and Media Contacts:
Meshing Technologies: Managing Wifi and Private 4G/5G with Public Carrier Networks
CCaaS and MSPs: The Perfect Partnership